Provider perceptions on the clinical utility of pharmacogenomics testing: views of psychiatry physicians from an academic center.

UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients.

Association of CYP2C19 gene single nucleotide polymorphisms (rs12248560 and rs4244285) with response to thalidomide in transfusion dependent β-thalassemia patients- a 12-months follow-up study.

The role of pharmacogenomics in managing cisplatin toxicity.

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.

Correction.

Provider perceptions on the clinical utility of pharmacogenomics testing: views of psychiatry physicians from an academic center.

UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients.

Association of CYP2C19 gene single nucleotide polymorphisms (rs12248560 and rs4244285) with response to thalidomide in transfusion dependent β-thalassemia patients- a 12-months follow-up study.

The role of pharmacogenomics in managing cisplatin toxicity.

ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.

Correction.